These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 16510126

  • 21. Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms.
    Renwick AB, Mistry H, Ball SE, Walters DG, Kao J, Lake BG.
    Xenobiotica; 1998 Apr; 28(4):337-48. PubMed ID: 9604298
    [Abstract] [Full Text] [Related]

  • 22. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM, Wester MR, Aramsombatdee E, Raucy JL.
    Arch Biochem Biophys; 1998 May 01; 353(1):16-28. PubMed ID: 9578596
    [Abstract] [Full Text] [Related]

  • 23. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.
    Hyland R, Jones BC, Smith DA.
    Drug Metab Dispos; 2003 May 01; 31(5):540-7. PubMed ID: 12695341
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD, Schmitz A, Theurillat R, Thormann W, Mevissen M.
    Am J Vet Res; 2011 Nov 01; 72(11):1505-13. PubMed ID: 22023129
    [Abstract] [Full Text] [Related]

  • 25. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
    Huskey SW, Dean DC, Miller RR, Rasmusson GH, Chiu SH.
    Drug Metab Dispos; 1995 Oct 01; 23(10):1126-35. PubMed ID: 8654202
    [Abstract] [Full Text] [Related]

  • 26. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
    Wójcikowski J, Pichard-Garcia L, Maurel P, Daniel WA.
    Br J Pharmacol; 2003 Apr 01; 138(8):1465-74. PubMed ID: 12721102
    [Abstract] [Full Text] [Related]

  • 27. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
    Koyama E, Chiba K, Tani M, Ishizaki T.
    J Pharmacol Exp Ther; 1997 Jun 01; 281(3):1199-210. PubMed ID: 9190854
    [Abstract] [Full Text] [Related]

  • 28. Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro.
    Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K.
    Drug Metab Dispos; 1999 Jul 01; 27(7):763-6. PubMed ID: 10383917
    [Abstract] [Full Text] [Related]

  • 29. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
    Yanagihara Y, Kariya S, Ohtani M, Uchino K, Aoyama T, Yamamura Y, Iga T.
    Drug Metab Dispos; 2001 Jun 01; 29(6):887-90. PubMed ID: 11353758
    [Abstract] [Full Text] [Related]

  • 30. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R, Yamaori S, Takeda S, Yamamoto I, Watanabe K.
    Life Sci; 2011 Aug 01; 89(5-6):165-70. PubMed ID: 21704641
    [Abstract] [Full Text] [Related]

  • 31. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
    Turpeinen M, Hofmann U, Klein K, Mürdter T, Schwab M, Zanger UM.
    Drug Metab Dispos; 2009 May 01; 37(5):1017-24. PubMed ID: 19204080
    [Abstract] [Full Text] [Related]

  • 32. Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential.
    Moody GC, Griffin SJ, Mather AN, McGinnity DF, Riley RJ.
    Xenobiotica; 1999 Jan 01; 29(1):53-75. PubMed ID: 10078840
    [Abstract] [Full Text] [Related]

  • 33. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
    Wang RW, Liu L, Cheng H.
    Drug Metab Dispos; 1996 Jul 01; 24(7):786-91. PubMed ID: 8818577
    [Abstract] [Full Text] [Related]

  • 34. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
    Wójcikowski J, Danek PJ, Basińska-Ziobroń A, Pukło R, Daniel WA.
    Pharmacol Rep; 2020 Jun 01; 72(3):612-621. PubMed ID: 32219694
    [Abstract] [Full Text] [Related]

  • 35. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
    Usmani KA, Chen WG, Sadeque AJ.
    Drug Metab Dispos; 2012 Apr 01; 40(4):761-71. PubMed ID: 22266842
    [Abstract] [Full Text] [Related]

  • 36. Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.
    Rochat B, Amey M, Gillet M, Meyer UA, Baumann P.
    Pharmacogenetics; 1997 Feb 01; 7(1):1-10. PubMed ID: 9110356
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.
    Coleman T, Ellis SW, Martin IJ, Lennard MS, Tucker GT.
    J Pharmacol Exp Ther; 1996 May 01; 277(2):685-90. PubMed ID: 8627546
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.